Hans Lennart Rudolf Wigzell

Hans Lennart Rudolf Wigzell founded Affibody Medical AB in 1998.
Dr. Wigzell also currently works at RaySearch Laboratories AB, as Chairman from 2022, Stockholm School of Entrepreneurship, as Chairman, PRFA Management AB, as Chairman, Biochromix Newco AB, as Chairman, Sarepta Therapeutics, Inc., as Independent Director from 2012, Humabs LLC, as Director from 2012, Gapminder Foundation, as Director, Wigzellproduktion AB, as Director, Royal Swedish Academy of Sciences, as Member, American Academy of Arts & Sciences, as Member, Royal Swedish Academy of Engineering Sciences, as Member, European Molecular Biology Organization, as Member, Finnish Society of Sciences & Letters, as Member, and Royal Danish Academy of Sciences & Letters, as Member.
Dr. Wigzell also formerly worked at Rhenman & Partners Asset Management AB, as Chairman, Karolinska Development AB, as Chairman from 2017 to 2020, ExThera AB, as Chairman, Intercell AG, as Director, Mertiva AB, as Director, NeoDynamics AB, as Director, Swedish Orphan Biovitrum AB, as Independent Director, Smittskyddsinstitutet, as General Director, Cadila Pharmaceuticals Sweden AB, as Director, National Bacteriological Laboratory, as General Director from 1987 to 1993, Probi AB, as Member-Supervisory Board, Biovitrum AB, as Member-Supervisory Board, Epixis SA, as Member-Supervisory Board, Valneva SE, as Independent Member-Supervisory Board from 2013 to 2016, and Karolinska Institutet, as President from 1995 to 2003.
Dr. Wigzell received his doctorate degree in 1967 from Karolinska Institutet.